08.11.26 - Is it too late to invest in Biotech stocks?

Biotech stocks have been quietly outperforming technology companies for over a year now, and some investors believe the rally is just getting started! On this episode of Market Sense, a Fidelity portfolio manager joins us to discuss the innovation driving this industry, including advances in obesity drugs, cancer treatments, and other cutting-edge therapies. We'll also examine the impact of AI in the biotech space, and the growing wave of mergers and acquisitions that have created new opportunities across the industry.
If you would like to research or learn more about the fund managed by this week’s Market Sense guest, click here
Read the full transcript
View the slides
Watch the video replay